Solar ultraviolet radiation (UVR) exposure of human skin has beneficial and harmful effects on health, including impact on immune function, inflammation and reportedly mood, but these are not fully elucidated. Since the endocannabinoid system is implicated in many activities including mood alteration, our objective was to (i) determine and quantify circulating levels of a wide range of endocannabinoid and N-acyl ethanolamine (NAE) species (ii) evaluate whether these are modulated by cutaneous UVR exposures, as attained through repeated low level summer sunlight exposure. Wearing goggles to prevent eye exposure, 16 healthy volunteers (23-59y; 10 light skin, phototype II, and 6 dark skin, phototype V) received the same UVR exposures (1.3 SED, 95% UVA/5% UVB) thrice weekly for 6 weeks, whilst casually dressed to expose ~35% skin surface area. Blood samples were taken at baseline, days 1, 3 and 5 of week one, then at weekly intervals, and analysed by LC-MS/MS. Eleven endocannabinoids and NAEs were detected and quantified at baseline, with Npalmitoyl ethanolamine the most abundant (30% of total). Levels did not vary according to phototype (p>0.05), except for the NAE docosapentaenoyl ethanolamide, which was higher in phototype II than V (p=0.0002). Level of the endocannabinoid, 2-AG, was elevated during the UVR exposure course (p<0.05 vs baseline for all subjects; p<0.01 for each phototype group), with maximum levels reached by week 2-3, while NAE species did not significantly alter. These findings suggest differential involvement of the cutaneous endocannabinoid system in low dose solar UVR responses in humans.
Herpes simplex virus. It is also observed that sunlight exposure causes a 'feelgood factor' or euphoria, which could be mediated by UVR. [2] [3] [4] Mood enhancement is observed in indoor tanning, where skin is exposed to the UVR component of sunlight alone; many individuals continue to self-expose despite knowledge of the adverse consequences, leading to the term 'tanorexia' or addictive-like tanning behaviour. 2, 3, 5 Whilst this phenomenon has been suspected to be attributable to circulating endorphins, akin to mood enhancement after intense exercise, 6 -endorphin is unable to cross the bloodbrain barrier 7 and investigations for a role of endorphins in tanorexia proved inconsistent. [8] [9] [10] [11] Whilst a potential opioid role continues to be explored, 12 and induction of withdrawal -like symptoms was observed after opioid blockade in frequent tanners, 13 recently, the endocannabinoid system has been implicated in 'runner's high,' with increased circulating levels of anandamide (AEA), which can cross the blood-brain barrier, detected after intense aerobic exercise. [14] [15] [16] [17] Recent studies evidence the extensive cutaneous profile of lipid mediators in human skin, encompassing the endocannabinoids, NAE, sphingolipids and eicosanoid families. [17] [18] [19] [20] [21] Some of these lipid species are known to be modulated by UVR and to play a role in photobiological effects in humans 22, 23 whilst the potential involvement of the endocannabinoids and their congeners in UVRinduced effects, awaits further exploration. The main endocannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), and a range of N-acyl ethanolamine (NAE) species, derive from membrane lipids ( Fig. 1 ). 24-26 AEA, 2-AG and some NAE species are physiological ligands for the G-protein coupled cannabinoid (CB) receptors, originally identified as the target for biologically active components of the cannabis plant. [27] [28] [29] They are active in neurotransmission in the central and peripheral nervous systems, including reduction in pain perception via CB1 and transient receptor potential vanilloid-1 receptors (TRV-1), 30 and show anti-inflammatory/immune-modulatory effects via peripheral CB2 receptors, including reduced IFN- and increased IL-10 secretion. 31 Although CB1 receptors were traditionally described in the central nervous system and CB2 peripherally as in immune cells, it has become evident their distribution is more variable and widespread throughout organ systems, including skin 21,32-33 which has been shown to possess a functional endocannabinoid system. 17 CB1 and CB2 receptors are expressed by keratinocytes and melanocytes, and also identified in sebocytes and hair follicles.
Recent evidence also suggests that the endocannabinoid system helps skin maintain homeostasis and respond to UVR challenge, with CB1/CB2-deficient mice experiencing increased allergic contact dermatitis 34 
MATERIALS AND METHODS

Study subjects and design
Healthy volunteers were recruited (January 2010). Exclusion criteria were pregnancy, breastfeeding, taking photoactive medication or supplements that contained vitamin D, a history of skin cancer or a photosensitivity disorder, and use of a sunbed or sunbathing in the 3 months prior to or during the study. Body mass index (in kg/m 2 ) was calculated as weight/height 2 . Ethical approval was obtained from the North Manchester Research Ethics Committee (reference 09/H1014/73), as part of a study examining additional UVR outcomes. 36 Informed consent was obtained and the study adhered to the principles of the Declaration of Helsinki. Participants proceeded through the study process as outlined in the protocol overview ( Fig 2) . Participants were white Caucasians of Fitzpatrick 37 sun-reactive skin type II (i.e. usually burns, sometimes tans) or of South Asian ethnicity with skin type V (brown skin).
Minimal erythemal dose (MED) assessment
The MED, defined as the lowest dose of UVR that produced a visually discernable erythema at 24 hours, was assessed in each subject prior to the exposure course, as a precaution. A geometric series of 10 doses (7-80mJ/cm 2 for phototype II, 26.6-271mJ/cm2 for phototype V) of erythemally weighted UVR was applied over 2 horizontal rows of buttock skin with a Waldmann UV 236B unit containing Waldmann CF-L 36W/UV6 lamps (peak emission: 313nm; range:
290-400nm; Waldmann GmbH, Villinge-Schwenningen, Germany).
Simulated summer sunlight UVR exposures
Volunteers were given a six-week course of UVR exposures 3x weekly (Monday, Wednesday and Friday at approximately the same time of day), concordant with the length of the summer school holiday period when the population is most exposed to sunlight, as previously described. 38 GraphPad Software, La Jolla, CA, USA). Serum concentrations were logarithmically transformed to make them normally distributed. Results were considered statistically significant if p<0.05.
RESULTS
Volunteer characteristics
Of the 18 recruited subjects, two of the eight South Asians dropped out early for personal reasons unrelated to the study; their results were not analysed. Table 1 displays baseline characteristics of participants.
The presence of AEA, 2-AG and NAE in human serum at baseline AEA, 2-AG and nine NAE species were detected and quantified in human serum.
These (Table 2 ). Figure 3A displays baseline levels of these eleven compounds.
When participants were analysed according to their skin type (II or V), baseline serum endocannabinoid and NAE levels were not statistically different between the two groups, apart from DPEA, which was higher in the phototype II cohort at Table 3 ; Fig 4) . (Tables 3A, 3B ). All major organ tissues may be contributing to these levels, including brain, liver and skin. Studies examining circulating levels in healthy humans are scarce. We found that prior to UVR exposure, median serum levels for most species were similar to recently reported values for healthy subjects, 41-43 including for AEA and 2-AG, while PEA was the most abundant NAE quantified. LEA, OEA and DHEA showed similar levels, while EPEA, DGLEA and DPEA had the lowest serum concentrations. However, STEA showed a median concentration of 697.1pg/ml, contrasting with ~6000ng/ml reported for "healthy controls" by Pavon et al. 42 The reason for the difference is unknown, although in the Pavon et al study it is not clear if those taking regular medications affecting fatty acid metabolism were excluded, and 17% subjects had received psychiatric treatment. 42 Interestingly, our ethnically different subject groups showed a DPEA level that was significantly higher in white Caucasians than South Asians. This may be attributable to the higher omega-3 fatty acid (as found in fish oil) dietary intake observed in white Caucasians than south Asians, 44, 45 as consumption of the omega-3 fatty acid eicosapentaenoic acid (EPA) leads to increased DPEA.
DISCUSSION
We discovered that circulating concentration of 2-AG was significantly raised during the course of UVR treatments (p<0.05), with the highest levels overall (median 1704pg/ml) achieved after 3 weeks, and no significant changes observed in other fatty acids after these low-level simulated summer exposures.
A lack of further increase in 2-AG levels after 3-4 weeks of 3x weekly exposures could imply saturation of endocannabinoid biosynthesizing enzymes, depletion of their precursors, saturation of CB receptors and/or photoadaptation.
Despite the sub-erythemal doses being fixed, i.e. 1.3 SED rather than individually MED-related, the same response was seen in both phototype II and V subjects, i.e. it occurred regardless of skin pigmentation. The differential increase in 2-AG and not other species may relate to their different biosynthetic pathways (Fig 1) . 46 Since UVR influences lipolytic enzymes including phospholipase C (PLC), 47 modifications could include increased release of diacylglycerol (DAG) from membrane phospholipids, 48 resulting in increased availability of DAG as 2-AG substrate. Indeed UVR exposure to keratinocyte cultures has been shown to increase endogenous DAG production. 47 Additionally, the catabolising enzymes FAAH and MAG lipase, found in many tissues, may reduce the concentration of metabolites produced post low-dose UVR, limiting the detection particularly of metabolites present at lower concentration than 2-AG. 49 Potentially, further UVR effects on endocannabinoids/NAEs might be observed with an increasing UVR-dosing schedule (more hazardous to skin), as can be found with deliberate sunbathing, indoor tanning or phototherapy regimes. A recent exploratory study by our group examined cutaneous endocannabinoid and NAE levels in skin biopsies taken 24 hours after UVR exposure to a localized area of the buttock, and found no alteration. 50 Implications of our study may include involvement of sunlight in mood control via the endocannabinoid system. Support for endocannabinoid activity in mood control includes studies in rats where depressive models had reduced AEA levels and differential changes in CB1 receptor binding density in the brain; 57 moreover, activation of the endocannabinoid system had anti-depressive effects mediated through CB1 receptors. 58 Human studies demonstrated reduced serum 2-AG and AEA levels in patients with untreated depression compared to controls. 59, 60 The endocannabinoids are hypothesized to activate CB1 receptors on brain GABA-ergic neurons, thereby increasing dopamine release in central reward centres, 61 while the neutrophin brain-derived neurotrophic factor, 17 and peripheral CB1 and CB2 receptor activation 62 may be involved. Responses of the skin endocannabinoid system might also contribute to mediation of UVRinduced skin inflammation, possibly mediated via alterations in arachidonic acid and prostaglandin levels, 46 and immunomodulation, including of cell-mediated immunity. 63 In mouse studies, genetic deletion or pharmacologic blockade of keratinocyte CB1 and CB2 receptors enhances allergic contact dermatitis, 34 potentially mediated through endocannabinoid regulation of monocyte chemotactic protein 2 (MCP-2)/chemokine ligand 8 (CCL8) expression. 64 Strengths of the study include the originality of this work, the Data are logged to achieve normality, and expressed as median, interquartile and full range. 
